Labetalol is indicated to treat hypertension (high blood pressure). It belongs to beta-blockers group of drugs. Beta-blockers affect the heart and circulation (blood flow through arteries and veins.
The LIGHTHOUSE™ Medical Emergency Kit is designed to meet the basic medical emergency needs of a dental practice treating patients ranging from pediatric to geriatric. The goal of the LIGHTHOUSE™ Medical Emergency Kit is to equip dental clinics with the required medications to be complaint by today's standard. As an owner of a LIGHTHOUSE™ Medical Emergency Kit, you are automatically enrolled in a program called "Automatic Replenishment". The program is a service exclusively offered by HANSAmed to track, monitor and replenish each individual medication in your LIGHTHOUSE™ Medical Emergency Kit prior to expiration. This service guarantees your medications will remain current and up to date. The medications and devices included in a LIGHTHOUSE™ Kit are quick, safe and easy to administer.
LighthouseTM provides dental clinics with vital medications, convenience, peace of mind and training to assist all dental staff in becoming equipped to handle a medical emergency in the office. With licensing and approval from Health Canada, we are able to provide clinics with quality medications to help you save a life.
- Labetalol Hydrochloride Injection USP is indicated for the emergency treatment of severe hypertension when prompt and urgent reduction of blood pressure is essential.
Warnings and Precautions:
- The most serious reported adverse effects of labetalol hydrochloride are severe postural hypotension, jaundice and bronchospasm.
- In well controlled clinical trials, the most common transient adverse reactions reported at routinely administered therapeutic doses, were postural hypotension and/or dizziness (16.9%), fatigue/malaise (13.1%), and headache (8.0%). Other transient effects include acute retention of urine and difficulty in micturition.
- Like other antiarrhythmics, Amiodarone Hydrochloride can exacerbate the arrhythmia, e.g., by making the arrhythmia less well tolerated or more difficult to reverse. This has occurred in 2 to 5% of patients in various series, and significant heart block or sinus bradycardia has been seen in 2 to 5%. All of these events should be manageable in the proper clinical setting in most cases.
- 1 vial of LIGHTHOUSE™ Labetalol 5mg/ml